The new kits will allow pharmacists to dispense the compounded prescriptions containing widely used proton pump inhibitors (PPIs). FIRST products will save dispensing time, and can be compounded
The EYLEA (aflibercept) injection was approved by the Food and Drug Administration for the treatment of neovascular (wet) age-related macular degeneration (AMD). Macular degeneration is diagnosed as either
Both the companies have entered into a strategic partnership to deliver a drug candidate. The long-term collaborative project includes three additional specific milestone targets. Hengrui global R&D president
The company will begin marketing and distributing Biocalth products throughout the US and expanding its revenue opportunities in the bone health and joint health market. The combined businesses
CO-1686 is a novel, oral, targeted covalent inhibitor of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). Clovis, in partnership with Avila Therapeutics, designed
Trimesta is an oral estriol designed for treating relapsing-remitting MS and for cognitive dysfunction in MS, both in female patients, and has been approved throughout Europe and Asia
The Filgrastim study is intended to assess the efficacy and safety of Sandoz’s biosimilar filgrastim versus Amgen’s Neupogen in breast cancer patients eligible for myelosuppressive chemotherapy treatment. The
The new product line will utilize G-Con Manufacturing’s novel modular, mobile clean-room pods and SSB’s broad single-use and reusable product portfolio to create a totally integrated production process
Levetiracetam in sodium chloride injection is an antiepileptic drug indicated for adults with different seizure types when oral administration is temporarily not feasible. The drug is used to
According to the company, the multicenter, randomized study will start in February 2012 and are scheduled to complete in the first quarter of 2013. The study, comparing ozenoxacin
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.